Pharmaceutical - Celsion

Filter

Current filters:

Celsion

Popular Filters

Celsion to acquire nucleic acid-based therapeutics firm EGEN

Celsion to acquire nucleic acid-based therapeutics firm EGEN

10-06-2014

US cancer drug developer Celsion Corp has entered into a definitive asset purchase agreement with EGEN,…

CelsionEGENMergers & AcquisitionsOncologyPharmaceutical

Celsion’s ThermoDox in combination treatment improves survival by more than 50%

27-01-2014

US cancer drug developer Celsion Corp (Nasdaq: CLSN) says that the latest overall survival data from…

CelsionOncologyPharmaceuticalResearchThermoDoxUSA

Zhejiang Hisun Pharma pulls out of ThermoDox deal with Celsion

07-02-2013

US cancer drug developer Celsion Corp (Nasdaq: CLSN) says that Zhejiang Hisun Pharmaceutical (SSE: 600267)…

Asia-PacificCelsionLicensingOncologyPatentsPharmaceuticalThermoDoxZhejiang Hisun Pharma

Celsion in ThermoDox technology deal for the greater China territory

24-01-2013

US cancer drug developer Celsion Corp (Nasdaq: CLSN) and Chinese drugmaker Zhejiang Hisun Pharmaceutical…

Asia-PacificCelsionLicensingMarkets & MarketingOncologyPharmaceuticalThermoDoxZhejiang Hisun Pharma

Parexel

Parexel

Back to top